Inhaled Budesonide for REcurrence Prevention and Adjuvant THerapy in Checkpoint Inhibitor Pneumonitis

NCT06860542 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Pneumonitis
Immune-related Adverse Event

Interventions

DRUG: Arm 2- Budesonide (Pulmicort® Turbuhaler®) + Usual care
OTHER: Arm 1- Usual care

Sponsor

AHS Cancer Control Alberta